The parallel regulation of REG3α, IL-6, and β-defensin-2 suggests that obesity-related inflammation extends beyond adipose tissue, involving the intestinal epithelium as both a source and a target of immune signaling. The gene discussed is IL6; the disease is obesity disorder.